Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche's business model revolves around innovation in both pharmaceuticals and diagnostics. The company invests heavily in R&D to bring new and effective treatments to market, particularly in oncology, immunology,...
Herceptin: Herceptin has been a cornerstone in the treatment of HER2-positive breast cancer. With a significant market share due to its efficacy and established presence, its growth has slowed down due to competition from biosimilars and newer therapies. Therefore, it is classified as a Cash Cow.
Avastin: Avastin is widely used for various types of cancer, including colorectal and lung cancer. While it holds a strong market share, its growth is moderate due to increasing competition and the emergence of alternative treatments. Hence, it f...
Our BCG tool allows you to fill out the matrix with your own products.
It's like ChatGPT but for your university course. Ask questions about your course material and get instant answers with citations.